Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Predict S.P.A. Class B ( (IT:PRE) ) has provided an announcement.
Predict S.p.A. announced the filing of an updated Statute with the Bari Business Register following the conversion of 150,000 Price Adjustment Shares into ordinary shares, maintaining the total share capital unchanged. This conversion reflects the company’s strategic adjustments in shareholding structure, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (IT:PRE) stock is a Buy with a EUR1.45 price target. To see the full list of analyst forecasts on Predict S.P.A. Class B stock, see the IT:PRE Stock Forecast page.
More about Predict S.P.A. Class B
Founded in 2008 in Bari, Predict S.p.A. is an innovative SME in the healthcare sector, focusing on in vivo diagnostics through ultrasound and radiological equipment distribution, and developing technologies in breath analysis and digital healthcare. The company operates through four Strategic Business Units, offering solutions in diagnostic imaging, breath analysis, augmented reality, and robotics, and has partnerships with leading Italian research institutes.
Average Trading Volume: 39,218
Technical Sentiment Signal: Strong Buy
Find detailed analytics on PRE stock on TipRanks’ Stock Analysis page.